In 2003, Al-Hajj et al. first isolated CD44+ CD24-/low breast cancer stem cells from breast cancer tissues, providing the initial evidence of the presence of tumor stem cells in solid tumors (Al-Hajj et al., 2003). Here, CD44 is linked to breast carcinoma.